Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Goodwill (2016 - 2025)

Historic Goodwill for Dexcom (DXCM) over the last 14 years, with Q4 2025 value amounting to $24.2 million.

  • Dexcom's Goodwill rose 614.04% to $24.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.2 million, marking a year-over-year increase of 614.04%. This contributed to the annual value of $24.2 million for FY2025, which is 614.04% up from last year.
  • Per Dexcom's latest filing, its Goodwill stood at $24.2 million for Q4 2025, which was up 614.04% from $24.1 million recorded in Q3 2025.
  • Dexcom's Goodwill's 5-year high stood at $26.6 million during Q1 2022, with a 5-year trough of $18.9 million in Q1 2021.
  • Over the past 5 years, Dexcom's median Goodwill value was $24.2 million (recorded in 2025), while the average stood at $24.1 million.
  • Per our database at Business Quant, Dexcom's Goodwill surged by 4074.07% in 2022 and then plummeted by 972.76% in 2024.
  • Quarter analysis of 5 years shows Dexcom's Goodwill stood at $26.5 million in 2021, then dropped by 3.02% to $25.7 million in 2022, then fell by 1.95% to $25.2 million in 2023, then decreased by 9.52% to $22.8 million in 2024, then increased by 6.14% to $24.2 million in 2025.
  • Its last three reported values are $24.2 million in Q4 2025, $24.1 million for Q3 2025, and $24.1 million during Q2 2025.